SciClone Pharmaceuticals, Inc. (SCLN) は上場企業です ヘルスケア セクターの Drug Manufacturers - Specialty & Generic 業界で事業展開.
SCLN を有する IPO日 1992-03-17, に上場 NASDAQ.
SciClone Pharmaceuticals, Inc. is a global biopharmaceutical company. The Company acquires, develops, and commercializes drugs for treating chronic and life-threatening diseases such as cancer, hepatitis B, hepatitis C, cystic fibrosis, and immune system disorders.